SII Covovax gets DCGI emergency use nod for 12 to 18 year olds Ruchika Sharma24 March 2022 12:09 PM ISTCovovax is the fourth vaccine to receive EUA from DCGI for use among adolescents 12 and older.
Infant COVID vaccine succeeded in trial: Moderna Ruchika Sharma24 March 2022 10:00 AM ISTCambridge: Moderna, Inc. has recently announced positive interim data from the Phase 2/3 KidCOVE study of the Moderna COVID-19 vaccine (mRNA-1273) in...
Mother to child transmission of COVID-19 infection, possible but rare Dr. Kamal Kant Kohli22 March 2022 9:15 AM ISTSARS-CoV-2, the virus causing the COVID-19 infection, can be transmitted from mother to baby before, during and after childbirth – but such...
Decoding REGEN-COV2 for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients Dr. Kamal Kant Kohli17 March 2022 11:45 AM ISTKidney transplant recipients are an immunocompromised population, with comorbid conditions such as obesity, diabetes, and coronary artery disease,...
Casirivimab and imdevimab in patients admitted to hospital with COVID-19: RECOVERY Trial Dr. Kamal Kant Kohli9 March 2022 5:19 PM ISTCasirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor-binding domain of the SARS-CoV-2...
Systemic Anticancer therapy in cancer patients alters Covid-19 outcomes: JAMA Medical Dialogues Editorial Team7 March 2022 9:00 AM ISTRecent active cancer based research suggests that current systemic anticancer therapies (SACTs) are not related with inferior COVID-19 infection...
PFIZER Clostridium difficile Vaccine did not meet primary endpoints: PHASE 3 CLOVER Trial MD Bureau6 March 2022 1:29 PM ISTNew York: Pfizer Inc. announced results from the CLOVER trial (CLOstridium difficile Vaccine Efficacy TRial), a pivotal Phase 3 study evaluating its...
Serum Institute seeks DCGI approval for phase 3 trial of Covovax as booster dose MD Bureau28 Feb 2022 12:35 PM ISTCovovax is approved by the European Medicines Agency for conditional marketing authorisation and also granted emergency use listing by WHO.
Cipla gets CDSCO panel green signal to conduct Paxlovid trials in India Roshni Dhar28 Feb 2022 12:10 PM ISTIn a significant development, drug-major Cipla has got a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Health Bulletin 26/February/2022 Roshni Dhar26 Feb 2022 4:13 PM ISTHere are top health stories for the dayIndia fears for its children as thousands of MBBS students stuck in Ukraine Amid the growing...
Coronavirus vaccine sales push Moderna to USD 12 billion profit in 2021 MD Bureau26 Feb 2022 3:47 PM ISTWashington: Moderna's COVID-19 vaccine brought in nearly USD 7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase...
New study raises suspicion of coronavirus being developed in lab MD Bureau26 Feb 2022 12:19 PM ISTThe scientist team, including Akhil Varshney from Dr Shroff Charity Eye Hospital in New Delhi, showed a tiny snippet of a genetic material owned by...
